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Background
While it has been used clinically in Europe since the
early 2000, molecular allergology remains relatively
unknown to a number of clinicians involved in the field
of allergy and this at a time when the understanding of
allergy at the level of proteins allows for novel diagnostic
and therapeutic avenues. Molecular allergy offers clini-
cians a better understanding of the allergy dynamics of
certain patients, particularly in some situations of food
allergy and in multi-allergy contexts.
Methods
A introduction to the science of molecular allergology,
based on 6 concepts has been developed. A concise yet
clinically effective “Molecular allergology summary 2013”
card has been devised so as to facilitate the allergy physi-
cian’s first steps in the clinical use of molecular allergo-
logy. Notions of molecular similarities and the relevance
of biologic testing results will be reviewed. This will assist
initial assessments of specific clinical contexts where
molecular allergology will prove particularly useful.
Results
A coherent appreciation of molecular families, their
major component markers and their clinical character
adds a whole new dimension to the evaluation and man-
agement of patients with various inhalant, nuts and
other food allergies. The oral allergy syndrome, from the
perspective of the molecular families at play, can be
better appreciated for the myriad of syndromes that
they really are, each with its own prognostic and thera-
peutic implications. The pertinence of molecular allergy
testing vis-à-vis multi-sensitized respiratory allergy
patients, milk and egg allergy management and other
more specific clinical conditions can be addressed.
Future applications of molecular allergy will likely change
considerably some of our therapeutic approaches.
Conclusions
Molecular allergy can enhance our care of allergy
patients today and opens new doors on allergy therapeu-
tics. It also brings new parameters and business-model
issues in allergy care in North-America. Beyond the help-
fulness of component-resolved diagnosis in the practice of
allergy medicine, the leadership of clinical allergists is
neeeded in defining its judicious application to the care of
our allergic patients.
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